Results 71 to 80 of about 6,823 (189)
Mycoses, Volume 69, Issue 6, June 2026.ABSTRACT Background Invasive pulmonary fungal infections (IPFIs) in immunocompromised children carry high morbidity and may interrupt life‐saving chemotherapy or haematopoietic stem cell transplantation (HSCT). Evidence on perioperative risk stratification for surgical management is limited.
Gang Yang +6 more
wiley +1 more source
Purpuric targetoid eruption revealing disseminated mucormycosis
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Francisco Mano, João Teixeira
wiley +1 more source
Transplant Infectious Disease, Volume 28, Issue 3, May/June 2026.Among patients referred for allogeneic hematopoietic cell transplantation with pulmonary opacities, lung biopsy provided a diagnosis in 72% of procedures and altered management in 51%. Despite a 7% major complication rate, lung biopsy frequently clarified noninfectious etiologies when bronchoscopy was inconclusive.
Sergio Rodriguez‐Rodriguez +8 more
wiley +1 more source
Cytomegalovirus pneumonia with pulmonary mucormycosis
Indian Journal of Pathology and Microbiology, 2008 Solid organ transplantation is becoming increasingly common in the treatment of end-stage organ failure. However, despite improvements in patient and allograft survival, immunosuppression-induced compromised cell-mediated immunity predisposes transplant recipients to opportunistic infections.
Mysorekar Vijaya, Rao Saraswati
openaire +3 more sources
Pulmonary Mucormycosis Treated With Lobectomy [PDF]
The Annals of Thoracic Surgery, 2017 A 57 year old man was referred from an outside facility for an unresolving pneumonia. Imaging of the chest demonstrated a right lung mass with a consolidation in the middle lobe, pleural effusion, and mediastinal lymphadenopathy. Cytologic examination of cultures from the bronchoscopy and thoracentesis did not yield a definitive diagnosis.
Oluwatobi, Afolayan +3 more
openaire +2 more sources
Pulmonary Mucormycosis with Diabetes Mellitus: A Case Report
, 2018 Mucormycosis is an uncommon but life threatening fungal infection that generally occurs mostly in immunocompromised patients. Patients do not respond to the antibiotics and so the condition may prove to be fatal if not timely detected. In this report, we
Shikha Jain, Bharat Sharma
core +1 more source
Diagnosis of Mucormycosis: Current Situation, Challenges and Future Prospects
Mycoses, Volume 69, Issue 4, April 2026.ABSTRACT Mucormycosis, an aggressive fungal infection caused by members of the order Mucorales, progresses rapidly and is associated with high mortality, particularly in immunocompromised hosts such as patients with uncontrolled diabetes, transplant recipients or those with COVID‐19‐associated immunosuppression. Early diagnosis remains challenging with
Yixuan Qu +3 more
wiley +1 more source
Invasive pulmonary mucormycosis: rare presentation with pulmonary eosinophilia
, 2017 Background Fungi can cause a variety of infectious diseases, including invasive mycosis and non-invasive mycosis, as well as allergic diseases. The different forms of mycosis usually have been described as mutually exclusive, independent entities, with ...
Tokiwa Tamai +12 more
core +1 more source
Clinical Case Reports, Volume 14, Issue 3, March 2026.ABSTRACT Infections caused by Syncephalastrum species in humans are relatively rare. However, clinicians must maintain a high suspicion for it in immunocompromised patients with cutaneous mucormycosis. Prompt histopathological and microbiological investigations, combined with timely antifungal therapy and surgical intervention, are crucial to prevent ...
Iqra Maryam +6 more
wiley +1 more source
Sequential morphological changes in follow-up CT of pulmonary mucormycosis [PDF]
, 2014 PURPOSEWe aimed to describe the computed tomography (CT) features of pulmonary mucormycosis including sequential changes between follow-ups. MATERIALS AND METHODSBetween June 2001 and May 2011, five patients (three males and two females; median age, 43 ...
Chang Hyun Lee +11 more
core +1 more source